The TNRC18 (Trinucleotide Repeat-Containing 18) antibody is a research tool designed to detect and study the TNRC18 protein, a relatively undercharacterized member of the trinucleotide repeat-containing protein family. TNRC18 is implicated in chromatin remodeling and transcriptional regulation, with potential roles in epigenetic silencing, DNA repair, or RNA processing. It contains multiple C-terminal motifs, including a conserved GATA-type zinc finger domain, suggesting interactions with nucleic acids or chromatin-associated proteins.
Antibodies targeting TNRC18 are primarily used in basic research to explore its expression patterns, subcellular localization (likely nuclear), and interactions with partners like HP1 (Heterochromatin Protein 1) or components of Polycomb repressive complexes. These antibodies enable techniques such as Western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP).
While TNRC18's exact biological functions remain unclear, studies link it to cellular senescence, cancer progression, and neurological disorders, particularly those involving triplet repeat expansions. Its association with heterochromatin maintenance and gene silencing pathways highlights its potential relevance in diseases driven by epigenetic dysregulation. Commercial TNRC18 antibodies are typically validated in human or murine models, but cross-reactivity with other species may require verification. Ongoing research aims to clarify its mechanistic contributions to chromatin dynamics and disease pathology.